The PI3K, Metabolic, and Autophagy Networks: Interactive Partners in Cellular Health and Disease

Annual Review of Pharmacology and Toxicology - Tập 53 Số 1 - Trang 89-106 - 2013
Naval P. Shanware1, Kevin Bray2, Robert T. Abraham3
1Oncology Research Unit, Pfizer Worldwide Research and Development, Pearl River, New York 10965, USA.
2Oncology Research Unit, Pfizer Worldwide Research and Development, Pearl River, New York 10965
3Oncology Research Unit, Pfizer Worldwide Research and Development, San Diego, California 92121;

Tóm tắt

A fundamental imperative for mammalian cells is to coordinate cell metabolism and growth with environmentally induced stress. This review focuses on three highly integrated networks—the phosphoinositide 3-kinase (PI3K) signaling cascade, intermediate metabolism, and autophagy—that work together to maintain cellular homeostasis under basal conditions and to drive cell-mass accumulation and cell cycle progression in the presence of appropriate mitogenic stimuli. Dysfunction within any one of these networks results in compensatory responses from the other networks. These responses underpin several pathologies associated with major human diseases such as cancer. We discuss the PI3K, metabolism, and autophagy networks and provide selected insights into internetwork cross-talk mechanisms. In recognition of the extensive interactions observed in both healthy and diseased cells, we propose that the three networks be merged into a “metabolism-signaling supernetwork.” A detailed understanding of this supernetwork will facilitate the development of novel therapies for cancer and other complex diseases.

Từ khóa


Tài liệu tham khảo

10.1126/science.296.5573.1655

10.1007/82_2010_67

10.1042/BST0340647

10.1006/smim.2001.0337

10.1007/s00018-002-8465-z

10.1038/nrm3290

10.1016/j.ccr.2009.06.006

10.1146/annurev.cellbio.17.1.615

10.1126/science.1106148

10.1016/j.cell.2007.06.009

10.1038/onc.2008.247

10.1038/onc.2008.245

10.1146/annurev-cellbio-092910-154237

10.1038/nrc2981

10.1038/nrd3504

10.1016/j.gde.2008.02.003

10.1085/jgp.8.6.519

10.1038/nrc1478

10.2967/jnumed.107.047258

10.1016/j.cell.2011.02.013

10.1016/j.gde.2009.10.009

10.1126/science.1160809

10.1038/ng.890

10.4103/0256-4947.75771

10.1038/nm.1890

10.2214/AJR.07.2496

10.1084/jem.102.1.37

10.1016/j.semcdb.2012.02.002

10.1007/s00109-011-0731-9

10.1038/nature07823

10.1073/pnas.0810199105

10.1083/jcb.200703099

10.1073/pnas.1003428107

10.1146/annurev-genet-102808-114910

10.1038/nature09204

10.1016/j.semcdb.2010.03.002

10.1083/jcb.200507002

10.1016/j.cell.2007.10.035

10.4161/auto.5.5.8566

10.1074/jbc.M702824200

10.1016/j.tibs.2012.02.008

10.1016/j.gde.2010.12.008

10.1038/nature03029

10.1083/jcb.200412022

10.1016/j.ccr.2006.06.001

10.1101/gad.1573107

10.1016/j.ceb.2009.12.003

10.1101/gad.2016211

10.1146/annurev.med.57.121304.131306

10.1038/nm0603-685

10.1158/0008-5472.CAN-09-2266

10.1126/science.1193497

10.1038/nature07976

10.1038/nrg1879

10.1038/ncb840

10.1186/1475-4924-2-20

10.1016/j.cmet.2006.04.005

10.1038/nature02866

10.1074/jbc.C300063200

10.1016/j.cmet.2010.12.005

10.1016/j.semcancer.2008.11.010

10.1038/378785a0

10.1038/onc.2008.25

10.1038/sj.onc.1208773

10.1074/jbc.M608372200

10.1016/j.cub.2009.09.058

10.1038/nrm3025

10.1038/emboj.2011.257

10.1038/emboj.2012.32

10.1146/annurev-pharmtox-010611-134537

10.1101/gad.2016311

10.1091/mbc.E10-06-0500

10.1101/gad.2016111

10.1177/1947601911408079

10.1073/pnas.1107969108

10.1126/scisignal.2000911

10.1042/BST0370289

10.1126/science.1207056

10.1038/onc.2010.177

10.1073/pnas.1013800108

10.1126/science.1205407

10.1038/nature09076

10.1016/j.molcel.2011.06.038

10.1038/ncb2168

10.1016/j.molcel.2012.01.010

10.1038/nrendo.2011.225

10.1074/jbc.M412357200

10.1089/ars.2008.2270

10.1016/j.tibs.2010.07.007

10.1210/jc.87.6.2474

10.1016/S1097-2765(02)00445-8

10.1158/1535-7163.MCT-07-2408

10.1097/CCO.0b013e32834b892d

10.2174/092986711796391651

10.1016/j.ccr.2010.10.031

10.1038/onc.2010.626

10.1158/1078-0432.CCR-10-2634

10.1016/S0006-2952(98)00217-2

10.1038/ncb0910-823

10.1016/j.ccr.2011.03.012